Cover Image
市場調查報告書

體外診斷 (IVD) 的美國市場:2015∼2019年

IVD Market in the US 2015-2019

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 331970
出版日期 內容資訊 英文 85 Pages
訂單完成後即時交付
價格
Back to Top
體外診斷 (IVD) 的美國市場:2015∼2019年 IVD Market in the US 2015-2019
出版日期: 2015年06月03日 內容資訊: 英文 85 Pages
簡介

體外診斷(IVD)檢查是有助於人類或動物的診斷、篩檢、疾病管理,並在已控管的環境下施行。由於IVD檢查對患者及醫療從業員而言都相當便利,也漸漸普及到照護現場和自我檢驗中。預測美國的IVD市場在2014年到2019年間將以年複合成長率(CAGR)5.45%的速度擴大。

本報告提供美國的IVD市場相關調查,提供您市場趨勢,2015∼2019年的成長預測,各市場區隔趨勢,及加入此市場的主要企業簡介等資訊。

第1章 摘要整理

第2章 簡稱清單

第3章 本報告的範圍

  • 市場概要
  • 產品概要

第4章 市場調查方法

第5章 簡介

第6章 美國的醫療改革

第7章 給付及補償對象:概要

第8章 市場環境

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第9章 各用途市場市場區隔

第10章 各技術市場區隔

第11章 各零件市場區隔

  • 消耗品
  • 設備
  • 服務

第12章 各終端用戶市場區隔

第13章 購買標準

第14章 市場成長的促進要素

第15章 促進要素與其影響

第16章 市場課題

第17章 促進要素的影響與課題

第18章 市場趨勢

第19章 趨勢及其影響

第20章 供應商環境

  • 競爭模式
  • 市場佔有率分析:2014年
  • 其他的潛力供應商

第21章 主要供應商分析

  • Abbott Diagnostics
  • BioMeriux
  • Danaher
  • Roche Diagnostics
  • Siemens Healthcare Diagnostics

第22章 本系列的其他報告

圖表

目錄
Product Code: IRTNTR5996

About IVD

IVD tests are helpful in diagnosis, screening, and disease management in humans and animals. These tests are usually performed in controlled environment, and they include blood analysis for the sign of infection and urine for the presence of glucose. The purpose of IVD test is not only to direct therapeutic effect but also to provide the health status of a patient. IVD plays an important role in supporting the decision making for clinical conditions. These advances have led to the development of point of care and self-test, which are easy and convenient for patients and medical professionals to use. The self-test include pregnancy test, blood glucose monitoring, cholesterol testing, infectious disease testing, and cardiac biomarker tests. IVD test can be performed in various settings, including clinical laboratory, a physician's office, or at home.

Technavio's analysts forecast the IVD market in the US to grow at a CAGR of 5.45% over the period 2014-2019.

Covered in this Report

This report covers the present scenario and the growth prospects of the IVD market in the US for the period 2015-2019. The market can be divided into three segments: consumables, instruments, and services. To calculate the market size, the report considers the revenue generated from the three segments.

Technavio's report, the IVD Market in the US 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report includes a discussion of the key vendors operating in this market.

Key Vendors

  • Abbott Laboratories
  • bioMerieux
  • Danaher
  • Roche Diagnostics
  • Siemens Healthcare

Other Prominent Vendors

  • A. Menarini Diagnostics
  • ARKRAY
  • Affymetrix
  • Agilent Technologies
  • Alere
  • Axis-Shield
  • Bio-Rad Laboratories
  • Bruker BioSciences
  • Cepheid
  • Dako
  • DiaSorin
  • ELITech
  • Eiken Chemical
  • Fujirebio Diagnostics
  • GE Healthcare
  • Grifols
  • Horiba
  • Illumina
  • Instrumentation Laboratory
  • Johnson & Johnson
  • Luminex
  • Magellan Biosciences
  • Nanosphere
  • Nova Biomedical
  • Nova Century Scientific
  • PerkinElmer
  • Phadia
  • QIAGEN
  • Quidel
  • Quest Diagnostics
  • Randox Laboratories
  • Sysmex Hematology
  • Tosoh
  • Trinity Biotech
  • Werfen Life Group

Market Driver

  • Changes in Healthcare System
  • For a full, detailed list, view our report

Market Challenge

  • Regulatory and Reimbursement Issues
  • For a full, detailed list, view our report

Market Trend

  • Move toward Real-time Personalized Treatment
  • For a full, detailed list, view our report

Key Questions Answered in this Report

  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. US Healthcare Reform

07. Reimbursement and Coverage: An Overview

08. Market Landscape

  • 08.1. Market Overview
  • 08.2. Market Size and Forecast
    • 08.2.1. Business Impact of Key Factors on Vendors
  • 08.3. Five Forces Analysis

09. Market Segmentation by Application

10. Market Segmentation by Technique

11. Market Segmentation by Component

  • 11.1. Consumables Market in US
    • 11.1.1. Market Size and Forecast
  • 11.2. Instruments Market in US
    • 11.2.1. Market Size and Forecast
  • 11.3. Services Market in US
    • 11.3.1. Market Size and Forecast

12. Market Segmentation by End-users

13. Buying Criteria

14. Market Growth Drivers

15. Drivers and their Impact

16. Market Challenges

17. Impact of Drivers and Challenges

18. Market Trends

19. Trends and their Impact

20. Vendor Landscape

  • 20.1. Competitive Scenario
    • 20.1.1. Key News
    • 20.1.2. Mergers and Acquisitions
  • 20.2. Market Share Analysis 2014
  • 20.3. Other Prominent Vendors

21. Key Vendor Analysis

  • 21.1. Abbott Diagnostics
    • 21.1.1. Key Facts
    • 21.1.2. Business Overview
    • 21.1.3. Geographical Presence
    • 21.1.4. SWOT Analysis
  • 21.2. BioMeriux
    • 21.2.1. Key Facts
    • 21.2.2. Business Overview
    • 21.2.3. Business Segmentation by Revenue 2013
    • 21.2.4. Geographical Segmentation by Revenue 2013
    • 21.2.5. Business Strategy
    • 21.2.6. Recent Developments
    • 21.2.7. SWOT Analysis
  • 21.3. Danaher
    • 21.3.1. Key Facts
    • 21.3.2. Business Overview
    • 21.3.3. Business Segmentation
    • 21.3.4. Revenue by Business Segmentation
    • 21.3.5. Revenue Comparison 2012 and 2013
    • 21.3.6. Segmentation by Geography
    • 21.3.7. Business Strategy
    • 21.3.8. Key Information
    • 21.3.9. SWOT Analysis
  • 21.4. Roche Diagnostics
    • 21.4.1. Key Facts
    • 21.4.2. Business Overview
    • 21.4.3. Business Segmentation by Revenue 2014
    • 21.4.4. Business Segmentation by Revenue 2013 and 2014
    • 21.4.5. Geographical Segmentation by Revenue 2014
    • 21.4.6. Business Strategy
    • 21.4.7. Recent Developments
    • 21.4.8. SWOT Analysis
  • 21.5. Siemens Healthcare Diagnostics
    • 21.5.1. Key Facts
    • 21.5.2. Business Overview
    • 21.5.3. SWOT Analysis

22. Other Reports in this Series

List of Exhibits

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Comparison of US Healthcare System Before and After Reforms
  • Exhibit 3: Reimbursement Perspectives of Healthcare Entities
  • Exhibit 4: IVD Market in US 2014-2019 ($ billions)
  • Exhibit 5: Segmentation of IVD Market in US by Application
  • Exhibit 6: Segmentation of IVD Market in US by Application 2014
  • Exhibit 7: Segmentation of IVD Market in US by Technique
  • Exhibit 8: Segmentation of IVD Market in US by Technique 2014
  • Exhibit 9: Segmentation of IVD Market in US by Component
  • Exhibit 10: Segmentation of IVD Market in US by Component 2014
  • Exhibit 11: Consumables Market in US 2014-2019 ($ billions)
  • Exhibit 12: Instruments Market in US 2014-2019 ($ billions)
  • Exhibit 13: Services Market in US 2014-2019 ($ billions)
  • Exhibit 14: Segmentation of IVD Market in US by End-users
  • Exhibit 15: Segmentation of IVD Market in US by End-users 2014
  • Exhibit 16: Abbott Laboratories: Key Takeaways
  • Exhibit 17: bioMerieux: Key Takeaways
  • Exhibit 18: Danaher: Key Takeaways
  • Exhibit 19: Roche Diagnostics: Key Takeaways
  • Exhibit 20: Siemens Healthcare: Key Takeaways
  • Exhibit 21: Abbott Diagnostics: Geographical Presence
  • Exhibit 22: bioMeriux: Business Segmentation by Revenue 2013
  • Exhibit 23: bioMeriux: Geographical Segmentation by Revenue 2013
  • Exhibit 24: Danaher: Business Segmentation
  • Exhibit 25: Danaher: Business Segmentation 2013
  • Exhibit 26: Danaher: Revenue by Business Segmentation 2012 and 2013 (US$ million)
  • Exhibit 27: Danaher: Revenue by Geographical Segmentation 2013
  • Exhibit 28: F. Hoffmann-La Roche Diagnostics: Business Segmentation by Revenue 2014
  • Exhibit 29: F. Hoffmann-La Roche Diagnostics: Business Segmentation by Revenue 2013 and 2014 ($ billion)
  • Exhibit 30: F. Hoffmann-La Roche Diagnostics: Geographical Segmentation by Revenue 2014
Back to Top